Study Conduct

ProSciento, OWL Metabolomics partner on NAFLD/NASH trial recruitment

Monday, June 12, 2017

ProSciento, a full scope clinical R&D services provider focused exclusively on metabolic diseases, and OWL Metabolomics, a biotechnology company pioneering virtual biopsy assays for the diagnosis of NAFLD/NASH, announced an exclusive, multi-year collaboration aimed at identifying individuals who are eligible for enrollment into clinical trials of therapeutic candidates to treat NAFLD (non-alcoholic fatty liver disease) and NASH (steatohepatitis).

[Read More]

TraceLink releases automated validation manager

Tuesday, June 6, 2017

TraceLink, a Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, announced Automated Validation Manager (AVM)—a web-based offering that automates the entire validation lifecycle of the TraceLink Life Sciences Cloud on an ongoing basis.

[Read More]

Acurian launches consulting services for clinical trial enrollment planning

Friday, May 19, 2017

Acurian, a full-service provider of global patient enrollment and retention solutions and a subsidiary of Pharmaceutical Product Development (PPD), has launched a new consulting offering to aid pharmaceutical sponsors in advance strategic planning for clinical trials enrollment. Acurian Consulting Services provides patient-centric, data-driven insights that help drive protocol design, patient enrollment feasibility, site and country planning, CRO selection and budgeting for central recruitment.

[Read More]